Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
University of California, San Diego
University of California, San Diego
Guangxi Medical University
Eastern Cooperative Oncology Group
Sichuan Cancer Hospital and Research Institute
Novartis
Prince of Songkla University
Memorial Sloan Kettering Cancer Center
Chinese University of Hong Kong
China Three Gorges University, Yichang, China
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Celgene
Dana-Farber Cancer Institute
Sun Yat-sen University
Roswell Park Cancer Institute
Hoffmann-La Roche
Alliance for Clinical Trials in Oncology
Sun Yat-sen University
Sanofi
ChineseAMS
University of Michigan Rogel Cancer Center
Sun Yat-sen University
University of Chicago
Fox Chase Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Sun Yat-sen University
Sun Yat-sen University
Sanofi
National Cancer Institute (NCI)
Sanofi